Cancer Research UK forms immunotherapy alliance
28-03-2019
Cancer Research UK invests £14m in biotherapeutics hub
19-09-2018
chrisdorney / Shutterstock.com
Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Cancer Research UK, SV Health Investors, cancer, oncology, funding, research and develpoment, Kudos Pharmaceuticals
